![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZFP14 |
Gene summary for ZFP14 |
![]() |
Gene information | Species | Human | Gene symbol | ZFP14 | Gene ID | 57677 |
Gene name | ZFP14 zinc finger protein | |
Gene Alias | ZNF531 | |
Cytomap | 19q13.12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q9HCL3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57677 | ZFP14 | HCC1_Meng | Human | Liver | HCC | 3.92e-37 | -4.37e-02 | 0.0246 |
57677 | ZFP14 | HCC2_Meng | Human | Liver | HCC | 1.04e-05 | -1.57e-02 | 0.0107 |
57677 | ZFP14 | cirrhotic1 | Human | Liver | Cirrhotic | 6.04e-04 | 1.15e-01 | 0.0202 |
57677 | ZFP14 | HCC1 | Human | Liver | HCC | 7.86e-19 | 2.93e+00 | 0.5336 |
57677 | ZFP14 | HCC2 | Human | Liver | HCC | 1.36e-25 | 2.39e+00 | 0.5341 |
57677 | ZFP14 | HCC5 | Human | Liver | HCC | 2.13e-16 | 1.92e+00 | 0.4932 |
57677 | ZFP14 | male-WTA | Human | Thyroid | PTC | 3.17e-03 | 8.66e-02 | 0.1037 |
57677 | ZFP14 | PTC01 | Human | Thyroid | PTC | 1.26e-06 | 1.58e-01 | 0.1899 |
57677 | ZFP14 | PTC04 | Human | Thyroid | PTC | 1.49e-07 | 1.48e-01 | 0.1927 |
57677 | ZFP14 | PTC05 | Human | Thyroid | PTC | 6.20e-13 | 4.66e-01 | 0.2065 |
57677 | ZFP14 | PTC06 | Human | Thyroid | PTC | 3.59e-18 | 3.74e-01 | 0.2057 |
57677 | ZFP14 | PTC07 | Human | Thyroid | PTC | 1.31e-19 | 3.08e-01 | 0.2044 |
57677 | ZFP14 | ATC12 | Human | Thyroid | ATC | 1.45e-02 | 1.19e-01 | 0.34 |
57677 | ZFP14 | ATC13 | Human | Thyroid | ATC | 2.12e-43 | 7.29e-01 | 0.34 |
57677 | ZFP14 | ATC1 | Human | Thyroid | ATC | 4.00e-02 | 1.41e-01 | 0.2878 |
57677 | ZFP14 | ATC4 | Human | Thyroid | ATC | 3.04e-06 | 1.62e-01 | 0.34 |
57677 | ZFP14 | ATC5 | Human | Thyroid | ATC | 9.23e-50 | 7.60e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZFP14 | BAS | Oral cavity | NEOLP | RARB,LOXL1,PRR16, etc. | 0.00e+00 | ![]() |
ZFP14 | GRA | Oral cavity | NEOLP | RARB,LOXL1,PRR16, etc. | 0.00e+00 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZFP14 | SNV | Missense_Mutation | c.952N>T | p.Gly318Trp | p.G318W | Q9HCL3 | protein_coding | deleterious(0.01) | possibly_damaging(0.861) | TCGA-86-8585-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
ZFP14 | SNV | Missense_Mutation | c.693N>C | p.Lys231Asn | p.K231N | Q9HCL3 | protein_coding | tolerated(0.1) | possibly_damaging(0.836) | TCGA-22-1011-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ZFP14 | SNV | Missense_Mutation | c.589G>A | p.Glu197Lys | p.E197K | Q9HCL3 | protein_coding | tolerated(0.09) | possibly_damaging(0.63) | TCGA-37-3789-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ZFP14 | SNV | Missense_Mutation | novel | c.154C>T | p.Pro52Ser | p.P52S | Q9HCL3 | protein_coding | deleterious(0.02) | benign(0) | TCGA-56-7222-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | PD |
ZFP14 | SNV | Missense_Mutation | c.1354T>C | p.Tyr452His | p.Y452H | Q9HCL3 | protein_coding | deleterious(0.05) | probably_damaging(0.996) | TCGA-60-2722-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | taxol | PD | |
ZFP14 | SNV | Missense_Mutation | c.224N>A | p.Arg75Lys | p.R75K | Q9HCL3 | protein_coding | tolerated(0.66) | benign(0) | TCGA-77-8144-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
ZFP14 | SNV | Missense_Mutation | novel | c.1242C>G | p.His414Gln | p.H414Q | Q9HCL3 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-85-8582-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ZFP14 | SNV | Missense_Mutation | novel | c.525N>T | p.Lys175Asn | p.K175N | Q9HCL3 | protein_coding | tolerated(0.22) | benign(0.019) | TCGA-94-A4VJ-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZFP14 | SNV | Missense_Mutation | c.128T>A | p.Ile43Asn | p.I43N | Q9HCL3 | protein_coding | deleterious(0) | benign(0.206) | TCGA-CN-4741-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | PD | |
ZFP14 | SNV | Missense_Mutation | c.818G>C | p.Arg273Pro | p.R273P | Q9HCL3 | protein_coding | tolerated(0.15) | benign(0.113) | TCGA-CV-A45Y-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |